Septal Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The septal nuclei are a group of neurons located in the basal forebrain that play crucial roles in memory, emotion, and autonomic function. They are a major component of the septohippocampal pathway and are heavily involved in cholinergic modulation of the hippocampus.
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
The septal nuclei are located in the medial aspect of the basal forebrain, adjacent to the midline. Key nuclei include:
- Medial septal nucleus (MS)
- Lateral septal nucleus (LS)
- Nucleus of the diagonal band (NDB)
- Triangular nucleus of the septum
- Mixed population of projection neurons and interneurons
- Projection neurons are primarily cholinergic
- Variety of sizes and shapes
- Hippocampal formation (via fimbria/fornix)
- Hypothalamus
- Brainstem nuclei
- Cerebral cortex
- Hippocampus: Major cholinergic and GABAergic projections
- Amygdala: Modulatory connections
- Hypothalamus: Autonomic regulation
- Cortex: Diffuse cholinergic projections
- Acetylcholine as primary neurotransmitter
- Express choline acetyltransferase (ChAT)
- Express vesicular acetylcholine transporter (VAChT)
- Co-localized with some cholinergic neurons
- Provide inhibitory modulation
- Express GAD67
- Neurotensin
- Parvalbumin
- Calretinin
- Severe loss of septal cholinergic neurons
- Primary target of neurodegeneration in AD
- Contributes to memory deficits
- Basis for current cholinergic treatments
- Cholinergic dysfunction contributes to cognitive symptoms
- Interaction with dopaminergic systems
- May contribute to dementia in PD
- Involvement of septal nuclei
- Contributes to autonomic dysfunction
- Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine)
- Target remaining septal cholinergic neurons
- Provide symptomatic relief
- Cell replacement therapy
- Neurotrophic factors (NGF, BDNF)
- Gene therapy approaches
The study of Septal Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Mesulam et al., Cholinergic system in the septal complex (1983)
- Wu et al., Septohippocampal system and memory (2000)
- Coyle & Price, Alzheimer's disease: cholinergic vulnerability (1983)